4DMT

Serial Number 97693523
Registration 7259698
700

Registration Progress

Application Filed
Nov 28, 2022
Under Examination
Approved for Publication
Oct 17, 2023
Published for Opposition
Oct 17, 2023
Registered
Jan 2, 2024

Trademark Image

4DMT

Basic Information

Serial Number
97693523
Registration Number
7259698
Filing Date
November 28, 2022
Registration Date
January 2, 2024
Published for Opposition
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 2, 2024
Registration
Registered
Classes
042

Rights Holder

4D MOLECULAR THERAPEUTICS INC.

03
Address
5858 Horton Street, Suite 455
Emeryville, CA 94608

Ownership History

4D MOLECULAR THERAPEUTICS INC.

Original Applicant
03
Emeryville, CA

4D MOLECULAR THERAPEUTICS INC.

Owner at Publication
03
Emeryville, CA

4D MOLECULAR THERAPEUTICS INC.

Original Registrant
03
Emeryville, CA

Legal Representation

Attorney
Adam K Sacharoff

USPTO Deadlines

Next Deadline
1616 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-02)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Jan 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Oct 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 11, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 1, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of pharmaceuticals; Scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Pharmaceutical products design and development for medical and scientific use, and medical treatment; Pharmaceutical drug design and development featuring biomolecules
First Use Anywhere: 20131200
First Use in Commerce: 20131200

Additional Information

Pseudo Mark
FOUR DMT

Classification

International Classes
042